Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Ipilimumab
×
Clear all
Filters
2
NCT03302234
2023-09-26
KEYNOTE-598
Merck Sharp & Dohme LLC
Phase 3
Completed
568 enrolled
20 charts
NCT01866319
2020-06-02
MK-3475-006
Merck Sharp & Dohme LLC
Phase 3
Completed
834 enrolled
13 charts